尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Freeman Jonathan E, 董事. Officer active across 1 company, notably Phio Pharmaceuticals Corp.. In total, 5 disclosures have been recorded. History available since 15 February 2022. The latest transaction was filed on 5 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Freeman Jonathan E is Administrateur at Phio Pharmaceuticals Corp. (XNAS). He has 5 filings in total, and the recent filings tracked run from 2022-02-16 to 2026-02-06, with the modal transaction nature shown as Attribution.